Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 26NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Prostatic Neoplasms 23Breast Neoplasms 23Carcinoma, Non-Small-Cell Lung 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Multiple Myeloma 14Lymphoma 12Colorectal Neoplasms 12Neoplasms 10Melanoma 9Lung Neoplasms 9Leukemia, Myeloid, Acute 8Pancreatic Neoplasms 7Lymphoma, Non-Hodgkin 7Wilms Tumor 6Leukemia, Biphenotypic, Acute 6Burkitt Lymphoma 6Squamous Cell Carcinoma of Head and Neck 5Lymphoma, Mantle-Cell 5Hematologic Neoplasms 5Head and Neck Neoplasms 5HIV Infections 5Ependymoma 5Endometrial Neoplasms 5Colonic Neoplasms 5Rectal Neoplasms 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Ovarian Neoplasms 4Osteosarcoma 4Neoplasm Metastasis 4

Interventions

Triptorelin Pamoate 1Standard of Care 1Specimen Handling 1Practice Guidelines as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Hematopoietic and Lymphatic System Neoplasm × 90 days × Clear all
NCT06513962 2026-05-05

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

Children's Oncology Group

Phase 3 Recruiting
60 enrolled
Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡